A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Head and Neck Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Nimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.
- Status
- COMPLETED
- Phase
- PHASE2
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
- Status
- RECRUITING
- Phase
- PHASE2
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2